AllianceBernstein
INBX icon

AllianceBernstein’s Inhibrx INBX Stock Holding History

AllianceBernstein’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$707K Hold
8,950
– – ﹤0.01% 2479
2025
Q4 		$707K Sell
8,950
-10,280
-53% -$700K ﹤0.01% 2487
2025
Q3 		$648K Sell
19,230
-1,190
-6% -$29.3K ﹤0.01% 2545
2025
Q2 		$291K Buy
20,420
+2,490
+14% +$32.2K ﹤0.01% 2926
2025
Q1 		$251K Hold
17,930
– – ﹤0.01% 2850
2024
Q4 		$276K Hold
17,930
– – ﹤0.01% 2916
2024
Q3 		$281K Sell
17,930
-1,280
-7% -$18K ﹤0.01% 2944
2024
Q2 		$272K Buy
+19,210
New +$300K ﹤0.01% 2946

Other funds holding INBX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

AllianceBernstein's INBX Position: Q1 2026 in Review

AllianceBernstein held its Inhibrx (INBX) position steady in Q1 2026 at 8,950 shares worth $707K. The position accounts for ﹤0.01% of the portfolio, ranked #2479.

AllianceBernstein first reported a position in INBX in Q2 2024 and has held it in 8 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

  • AllianceBernstein held 8,950 shares of Inhibrx worth $707K as of Q1 2026.
  • AllianceBernstein left its Inhibrx share count unchanged in Q1 2026.
  • Inhibrx made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2479 holding.
  • AllianceBernstein first reported a position in Inhibrx in Q2 2024 and has held it in 8 quarters since.
  • 135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.